Home Cart Sign in  
Chemical Structure| 314054-00-7 Chemical Structure| 314054-00-7

Structure of C-176
CAS No.: 314054-00-7

Chemical Structure| 314054-00-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

C-176 is a STING inhibitor with anti-inflammatory effection.

Synonyms: C-176

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of C-176

CAS No. :314054-00-7
Formula : C11H7IN2O4
M.W : 358.09
SMILES Code : O=C(C1=CC=C([N+]([O-])=O)O1)NC2=CC=C(I)C=C2
Synonyms :
C-176
InChI Key :JBIKQXOZLBLMKI-UHFFFAOYSA-N
Pubchem ID :1103958

Safety of C-176

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HK-2 cells 3 μM 48 h Inhibited STING signaling pathway, alleviated hypoxia-induced fibrosis and inflammatory responses PMC11228024
dTHP-1 cells 1 μM 1 h Pretreatment with C-176 significantly decreased the mRNA expression of IFN-β and IL-1β and slightly reduced the phosphorylation of NF-κB p65. Additionally, C-176 pretreatment suppressed the cleavage of caspase-1 and GSDMD, indicating that the STING signaling pathway is not involved in noncanonical inflammasome activation during HAdV infection. PMC10167768
Human aortic smooth muscle cells (hVSMCs) 1 µM 1 h Inhibited CKD serum-induced IFN-I response, premature senescence, and phenotypic switching PMC7927614
MPC5 mouse podocytes 1 µM C176 ameliorated palmitic acid (PA)-induced podocyte injury, as evidenced by restored protein levels of nephrin and podocin, reduced apoptosis, decreased phosphorylation of TBK1 and NF-κB p65, and reduced levels of IL-6 and TNF-α. PMC9513272
H446 cells 3 μM 6 days To study SAHA-induced senescence and its effect on SASP secretion, results showed that H446 cells treated with SAHA exhibited significant senescence phenotype and promoted SASP secretion. PMC10404275
H1688 cells 3 μM 6 days To study SAHA-induced senescence and its effect on SASP secretion, results showed that H1688 cells exhibited senescence phenotype 2 days after SAHA withdrawal and promoted SASP secretion. PMC10404275
BV2 cells 0.5 μM 1 h To investigate the anti-inflammatory effects and mechanisms of C-176 in an in vitro SAH model, results showed that C-176 significantly decreased the expression of M1 microglial markers and upregulated AMPK phosphorylation. PMC7247752

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Oxidative stress-induced retina degeneration model Intraperitoneal injection 10 mg/kg Once daily for 3 days C176 inhibited SI-induced cGAS-STING activation and reduced retina destruction and subretinal immune cell infiltration. PMC9433402
Mice Unilateral ureteral obstruction (UUO) model Intraperitoneal injection 750 nM/mouse Once daily for 14 days Inhibited STING signaling pathway, alleviated UUO-induced renal fibrosis and inflammation PMC11228024
Mice LLC lung metastasis model Intraperitoneal injection 13.4 mg/kg Once daily for 24 days STING inhibition significantly reversed the STING-activated DC maturation and migration in Tfam-/- mice and promoted tumor progression and metastasis PMC9980377
Mice Subcutaneous xenograft model Intraperitoneal injection 5 mg/kg Once daily for 7 days To evaluate the effect of C-176 on the GPR162-STING signaling pathway induced by radiotherapy, results showed that C-176 significantly reduced the anti-tumor effect of radiotherapy PMC9892510
Mice CKD/ApoE−/− mice Intraperitoneal injection 4 mg/kg Every other day for 12 weeks Significantly retarded AS progression and improved plaque vulnerability PMC7927614
Mice db/db mice Intraperitoneal injection 5 mg/kg Once daily for 21 consecutive days C176 inhibited the cGAS-STING pathway and ameliorated podocyte injury in db/db mice, as evidenced by reduced microalbuminuria, alleviated glomerular hypertrophy and mesangial expansion, restored nephrin levels, and reduced podocyte apoptosis. PMC9513272
C57BL/6J mice Subarachnoid hemorrhage (SAH) model Intraperitoneal injection 750 nM, 200 μL Single dose, 30 minutes post-modeling To investigate the neuroprotective effects and mechanisms of C-176 in an SAH model, results showed that C-176 significantly attenuated brain edema, neuronal injury, and improved both short-term and persistent neurological dysfunction, with its anti-inflammatory effects partially mediated by AMPK signaling. PMC7247752

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01308658 Healthy Phase 1 Completed - Germany ... More >> Berlin, Germany Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.79mL

0.56mL

0.28mL

13.96mL

2.79mL

1.40mL

27.93mL

5.59mL

2.79mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories